U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT06943625) titled 'Combined Effects of Green Light and Transcranial Direct Current Stimulation in Migraine Patients.' on April 17.
Brief Summary: According to the Global Burden of Disease (GBD) study, headache disorders are among the most prevalent and disabling conditions worldwide, with estimated 1-year prevalence of migraine (22.5%) in Pakistan, considerably higher than the global 1-year prevalence of 15%.
The treatment options comprise such as lifestyle modifications, behavioral therapy, medication such as nonsteroidal anti-inflammatory drugs (NSAIDs), beta blockers, calcium channel blockers, antiepileptic drugs or antibodies against calcitonin ...